ADVB
Advanced Biomed Inc. Common Stock
NASDAQ: ADVB · HEALTHCARE · DIAGNOSTICS & RESEARCH
$5.30
+0.00% today
Updated 2026-04-29
Market cap
$7.23M
P/E ratio
1.51
P/S ratio
—
EPS (TTM)
$3.52
Dividend yield
—
52W range
$4 – $49
Volume
0.7M
Advanced Biomed Inc. Common Stock (ADVB) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | — |
| Revenue growth (YoY) | — | — | — | — | — |
| Cost of revenue | $2031.00 | $4477.00 | $11888.00 | $12550.00 | $10711.00 |
| Gross profit | $-2031.00 | $-4477.00 | $-11888.00 | $-12550.00 | $-10711.00 |
| Gross margin | — | — | — | — | — |
| R&D | $1.73M | $1.62M | $1.38M | $880193.00 | $28341.00 |
| SG&A | $44470.00 | $624774.00 | $1.32M | $1.26M | $2.11B |
| Operating income | $-1.84M | $-2.37M | $-3.07M | $-2.54M | $-94112.00 |
| Operating margin | — | — | — | — | — |
| EBITDA | $-1.78M | $-2.24M | $-2.71M | $-2.14M | $-90815.00 |
| EBITDA margin | — | — | — | — | — |
| EBIT | $-1.84M | $-2.37M | $-3.07M | $-2.54M | $-101526.00 |
| Interest expense | — | — | — | — | — |
| Income tax | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-1.84M | $-4.03M | $-3.73M | $-2.78M | $-101524.00 |
| Net income growth (YoY) | — | -119.2% | +7.3% | +25.5% | +96.4% |
| Profit margin | — | — | — | — | — |